← Eichor
Study identifier: NCT03859050 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Alveolar Macrophage Programming Following Endotoxin Exposure

Condition: ARDS, Human  ·  Sponsor: National Jewish Health

PhaseNA
Planned participants25
Who can joinAll sexes, 18 Years to 50 Years
Healthy volunteersYes

About this study

The histologic hallmarks of lung inflammation include accumulation of inflammatory cells in the airspaces and interstitium, injury to alveolar epithelial and endothelial cells, loss of epithelial-capillary integrity and accumulation of edema fluid in the interstitium and airspaces. Accordingly, for alveolar repair to occur inflammation must be halted, debris and inflammatory cells removed, injured tissue cells replaced, and capillary barrier function re-established. Macrophages are key players in all of these. Here the investigators hypothesize that resident alveolar macrophages and recruited macrophages serve completely different functions, acting independently (i.e. division of labor) yet cooperatively (synergism).

This description comes directly from the study's public registry record.

Talk to the study team

Kara Mould  ·  303-398-1787  ·  mouldk@njhealth.org

Always discuss trial participation with your own doctor first.

Locations (1)

National Jewish HealthDenver, Colorado, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03859050